Loading…

Embolization of Blood Vessels as a Cancer Therapy Using Magnetorheological Fluids

This paper demonstrates a possible in vitro cancer therapy by mechanically blocking the blood vessels to a tumor through injecting a model magnetorheological (MR) fluid and applying an external magnetic field. The biocompatible MR fluid is made of magnetite particles coated with starch and suspended...

Full description

Saved in:
Bibliographic Details
Published in:Journal of intelligent material systems and structures 2002-10, Vol.13 (10), p.641-646
Main Authors: Flores, G. A., Liu, J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This paper demonstrates a possible in vitro cancer therapy by mechanically blocking the blood vessels to a tumor through injecting a model magnetorheological (MR) fluid and applying an external magnetic field. The biocompatible MR fluid is made of magnetite particles coated with starch and suspended in either water or sheep blood. Two particle sizes of 1.0 and 0.25 μm are used. A simple blood network consists of four branches of blood vessels made of silicone tubes of 0.4 mm in diameter. One of the branches contains a tumor made of a cylindrical cavity with a diameter of either 3.0 or 5.0 mm to simulate stage II or III tumors. The cavity is connected with either two or four vessels to the rest of the branch and is placed between two magnetic poles. By measuring the weight of the leaking fluid downstream from the magnets, the sealing quality is monitored. A dilute MR fluid (1.0% particle volume fraction) is pumped slowly through the network. As the fluid goes through the cavity, seals form within seconds after a magnetic field (0.43-0.62 T) is turned on. They block the fluid flow to the tumor. With sheep blood as the suspension medium, both size of magnetite particles form a good quality seal for the 3 mm cavity. Thus, a mechanical method for stopping blood flow is demonstrated in a multi-tube blood network for stage II tumor.
ISSN:1045-389X
1530-8138
DOI:10.1177/1045389X02013010006